Immuno Cure
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $12M
Investors
- 1
About Immuno Cure
42PD1 antibody drug platform. The company is headquartered in Hong Kong and has branches in Beijing, Shanghai and Shenzhen..,Ltd. In June 2023, the company initiated clinical phase IIa trial in Hong Kong. Xia Jin, the CEO and co-founder of the company, once served as the distinguished fellow of the Chinese Academy of Sciences and executive director of the Vaccine Center at the Shanghai Pasteur Institute. The company has many strategic partners, such as Teresa, Opus Capital and The University of Hong Kong Shenzhen Hospital.42PD1 antibody drug platform. DNA vaccine platform can inhibit viruses and tumor cells.42PD1 antibody drug platform can reduce inflammatory response. Its R&D pipeline includes IMC-001, IMC-002 and IMC-003.
Who invested in Immuno Cure
1 investor across 1 round
See all investors in Immuno Cure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 27, 2023
Amount
$12M
Investors
Questions about Immuno Cure
Who invested in Immuno Cure?
Immuno Cure has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immuno Cure raised?
Immuno Cure has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Immuno Cure last raise money?
Immuno Cure's most recent round on record is a Series A, in Jul 2023.
What does Immuno Cure do?
Immuno Cure is a biotechnology company.
Where is Immuno Cure headquartered?
Immuno Cure is headquartered in Sha Tin, Hong Kong SAR - China.
Which VCs invest in companies like Immuno Cure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Immuno Cure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Immuno Cure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.